Zobrazeno 1 - 10
of 139
pro vyhledávání: '"Brendan P, Halloran"'
Autor:
Brendan P. Halloran, Matthew Reeson, Christopher Teshima, Karen Kroeker, Vivian Huang, Levinus Dieleman, Peter Holmes, Daniel C. Baumgart, Karen Wong, Frank Hoentjen, Farhad Peerani, Sergio Zepeda-Gomez
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: Despite recent emerging literature involving the utility of endoscopic balloon dilation (EBD) of strictures via balloon-assisted endoscopy (BAE), specifically regarding the management of Crohn’s disease (CD), the optimal clinical approa
Externí odkaz:
https://doaj.org/article/7db1a9b2379f4c5b8361d7f25d0eac92
Autor:
Sergio Zepeda-Gómez, Andrea Dávila-Cervantes, Aldo J. Montaño-Loza, David Yang, Daniel C. Baumgart, Karen Kroeker, Brendan P. Halloran
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Objectives The tracking and documentation of procedures in gastrointestinal endoscopy including therapeutic interventions is an essential but challenging process. The University of Alberta has developed a smartphone app to help facilitate th
Externí odkaz:
https://doaj.org/article/a6b4c256ffcd46ca8f650651226f0cee
Autor:
Farhad Peerani, Makayla Watt, Kathleen P Ismond, Reid Whitlock, Lindsy Ambrosio, Naomi Hotte, Nicholas Mitchell, Robert J Bailey, Karen Kroeker, Levinus A Dieleman, Jesse Siffledeen, Allen Lim, Karen Wong, Brendan P Halloran, Daniel C Baumgart, Lorian Taylor, Maitreyi Raman, Karen L Madsen, Puneeta Tandon
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Psychological stress negatively impacts inflammatory bowel disease (IBD) outcomes. Patients have prioritized access to online interventions; yet, the data on these have been limited by mixed in-person/online interventions, low adherence,
Externí odkaz:
https://doaj.org/article/d3602a1a8b3d476eafe3aa308d64cac1
Autor:
Christopher Ma, Chad J Evaschesen, Grenvil Gracias, Vivian W Huang, Darryl K Fedorak, Karen I Kroeker, Levinus A Dieleman, Brendan P Halloran, Richard N Fedorak
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 29, Iss 6, Pp 309-314 (2015)
BACKGROUND: Adherence to maintenance medication regimens in inflammatory bowel disease patients has traditionally been poor. Although infliximab has demonstrated efficacy in inducing and maintaining disease remission, adherence to regularly scheduled
Externí odkaz:
https://doaj.org/article/8dfd2d200003405ead0b6d20c4c75971
Autor:
Vivian Wai-Mei Huang, Neil Dhami, Darryl Fedorak, Connie Prosser, Carol Shalapay, Karen Ivy Kroeker, Brendan Phillip Halloran, Levinus Albert Dieleman, Richard Neil Fedorak
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 29, Iss 1, Pp 35-40 (2015)
BACKGROUND: Although infliximab is an effective therapy for inflammatory bowel disease (IBD), it is associated with dermatological events and infusion reactions. It is not known whether a relationship between these adverse events (AEs) and infliximab
Externí odkaz:
https://doaj.org/article/7fb919bec55d4ed5a6770c3fcb2db2cc
Autor:
Brendan P. Halloran, Daniel C. Baumgart, Karen I. Kroeker, Bhairavi Balram, Levinus A. Dieleman, Harshad Joshi, Farhad Peerani, Karen Wong
Publikováno v:
Digestive Diseases and Sciences. 66:3985-3992
While there is recent literature to support the discontinuation of 5-aminosalicylate (5-ASA) upon the initiation of biologics, continuing 5-ASA after treatment failure is relatively common. We aimed to assess the impact of concomitant 5-ASA therapy o
Autor:
Laith H. Jamil, Gil Y. Melmed, Brendan P. Halloran, Neel K Mann, Andrew Ippoliti, Eric A. Vasiliauskas, Matt Reeson, Stephan R. Targan, Simon K. Lo
Publikováno v:
Inflammatory Bowel Diseases. 27:1248-1255
Background Crohn disease (CD) affects the small bowel in 80% of patients. Double balloon endoscopy (DBE) provides the potential for direct and extensive mucosal visualization with the potential for diagnostic monitoring and therapeutic intervention.
Autor:
Christopher Ma, Candace L. Beilman, Vivian W. Huang, Darryl K. Fedorak, Karen Wong, Karen I. Kroeker, Levinus A. Dieleman, Brendan P. Halloran, Richard N. Fedorak
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2016 (2016)
Background. Biologic agents targeting tumor necrosis factor alpha are effective in the management of ulcerative colitis (UC), but their use is often postponed until after failure of other treatment modalities. Objectives. We aim to determine if earli
Externí odkaz:
https://doaj.org/article/db443bce54454ce18e95da9f882fdc0f
Autor:
Candace L. Beilman, Nguyen Xuan Thanh, Victoria Ung, Christopher Ma, Karen Wong, Karen I. Kroeker, Thomas Lee, Haili Wang, Arto Ohinmaa, Phil Jacobs, Brendan P. Halloran, Richard N. Fedorak
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2016 (2016)
Background. Adalimumab is effective for the maintenance of remission in patients with moderate-to-severe ulcerative colitis (UC). Currently, biologic therapies are used in cases where patients fail conventional medical therapies. If biologic therapie
Externí odkaz:
https://doaj.org/article/3eca1e9914c54b52961f955879dd72ca
Autor:
Brendan P. Halloran, Matthew Reeson, Christopher W. Teshima, Jesse Siffledeen, Karen I. Kroeker, Vivian Huang, Levinus A. Dieleman, Karen Wong, Frank Hoentjen, Farhad Peerani, Daniel C. Baumgart, Sergio Zepeda-Gomez
Publikováno v:
Gastrointestinal Endoscopy. 95:AB104-AB105